← Back to Clinical Trials
Recruiting NCT04007380

NCT04007380 Psychosocial, Cognitive, and Behavioral Consequences of Sleep-disordered Breathing After SCI

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04007380
Status Recruiting
Phase
Sponsor University Health Network, Toronto
Condition Spinal Cord Injuries
Study Type INTERVENTIONAL
Enrollment 24 participants
Start Date 2019-09-27
Primary Completion 2025-08-30

Trial Parameters

Condition Spinal Cord Injuries
Sponsor University Health Network, Toronto
Study Type INTERVENTIONAL
Phase N/A
Enrollment 24
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2019-09-27
Completion 2025-08-30
Interventions
Continuous positive airway pressure (CPAP) therapy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This clinical trial will examine the efficacy of continuous positive airway pressure (CPAP) therapy in improving psychosocial, neurocognitive and behavioral consequences of moderate-to-severe sleep-related breathing disorders (SRBDs) in people living with spinal cord injury (SCI).

Eligibility Criteria

Inclusion Criteria: * English-speaking adults 18 years of age or older * Have traumatic cervical/thoracic (injury level at C5 to T10), severe or moderate (AIS A, B, or C) SCI who were not diagnosed with a sleep disorder prior to the injury. * At least 2 months after injury * Clinical warning symptoms and/or signs for SRBDs Exclusion Criteria: * Patients with a non-traumatic spinal cord disease at risk for neurologic progression * Concomitant diseases of the central nervous system * Preinjury chronic pain * Psychiatric disorders that may prevent the participant to be compliant to the study protocol requirements * Neuromuscular diseases * Current substance misuse * History of primary hypersomnia * Hypothyroidism * Moderate or severe iron deficiency anemia * Active infection * Kidney failure * Epilepsy * Chronic fatigue syndrome * Vitamin B12 deficiency

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology